Secondary Logo

Journal Logo

November 2021 - Volume 209 - Issue 11

  • John A. Talbott, MD
  • 0022-3018
  • 1539-736X
  • 12 issues / year
  • Clinical Neurology 155/208, Psychiatry 116/156
  • 2.254


Application Deadline: November 30, 2020

The Journal of Nervous and Mental Disease seeks Diversity Editorial Fellows. Applicants should have: an MD or PhD degree, at least two years of psychiatry and neurology training with research activity, completed clinical specialty training, an interest in diversity, equity and inclusion and hold faculty positions at the instructor or assistant professor level or other junior faculty level equivalent. Candidates who have published peer-reviewed papers, have strong knowledge of psychiatry and neurology science, and a record of commitment to and achievement in academic medicine are encouraged to apply. For more information on this opportunity, please click on this link. To apply, please submit your CV and one-page letter describing your interest and how your skills, experience and interests match the requirements to [email protected]. Candidates invited for an interview will be asked to disclose conflicts of interest. 

JAT photo 2.jpgIn this issue we are publishing an article by Silverman et al dealing with the public's opinion on the effectiveness of CBT versus drugs.  Like many, when drugs appeared on the scene, I was enthusiastic that we finally had treatments for many crippling mental disorders.  

Then, when Tim (everyone calls him Tim, but I have good reason) Beck showed that psychotherapy​ was a powerful therapy,  I was equally enthusiastic.

As time went on, CBT was shown effective in disease after disease, so much so that I worried it might be seen as a placebo on steroids. In addition, some studies showed it was as effective as drugs in certain conditions.

The public has caught on and CBT now has credibility that some other psychotherapies do not.  When the public understands as much of the science as they do now, I think it's a ​very good thing.

For this we can thank the intelligent press, principally the New York Times which when I was a medical student had one part time physician writer, Howard Rusk, a rehab doc and now employs a squadron.  The press takes a lot of knocks but for informing us about medical innovation, it gets high marks.

John A. Talbott, MD 

Psychiatry in the Time of COVID: Credibility, Uncertainty, and Self-Reflection

Adler, David A.; Erlich, Matthew D.; Goldman, Beth; More

The Journal of Nervous and Mental Disease. 209(11):779-782, November 2021.

Current Issue Highlights


Psychiatry in the Time of COVID: Credibility, Uncertainty, and Self-Reflection

Adler, David A.; Erlich, Matthew D.; Goldman, Beth; More

The Journal of Nervous and Mental Disease. 209(11):779-782, November 2021.